U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Glipizide Tablet, Extended Release
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Pfizer Inc. (New 08/09/2023)

Company Contact Information:
800-533-4535

Presentation Posting Date Related Information
Glipizide XL, Tablet, Extended Release, 5 mg (NDC 59762-0541-2) 08/09/2023 Discontinuation of the manufacture of the drug
Glipizide XL, Tablet, Extended Release, 10 mg (NDC 59762-0542-2) 08/09/2023 Supply expected to exhaust October 2023
Glipizide XL, Tablet, Extended Release, 5 mg (NDC 59762-0541-1) 08/09/2023 Discontinuation of the manufacture of the drug
Glipizide XL, Tablet, Extended Release, 10 mg (NDC 59762-0542-1) 08/09/2023 Discontinuation of the manufacture of the drug
Glucotrol XL, Tablet, Extended Release, 10 mg (NDC 0049-0178-07) 08/09/2023 Supply expected to exhaust November 2023
Glipizide XL, Tablet, Extended Release, 2.5 mg (NDC 59762-0540-1) 08/09/2023 Discontinuation of the manufacture of the drug
Back to Top